Back to
FRANKLIN TEMPLETON INC
BIOA2 quarters
Position history for
FRANKLIN TEMPLETON INC's holdings in BIOAGE LABS INC
Yes. Franklin Templeton holds 281,967 shares of BIOA (Bioage Labs), worth $6.9M, as of its Q2 2026 13F filing. It increased the position by 16,594 shares (+6.3%) from Q1 2026. Franklin Templeton has held BIOA since Q1 2026, across 2 quarterly 13F filings.
Current Value
$6.9M
Current Shares
281,967
Total Value Change
+$2.3M
Total Shares Change
+16,594
Quarter-by-Quarter History
Other major holders of BIOA: BlackRock, Inc., Jupiter Topco LLC, RA CAPITAL MANAGEMENT, L.P.